Global Biopolar Disorder Therapeutics Market 2015-2019 - New Market Study Published

Boston, MA -- (SBWire) -- 01/11/2016 --Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in for treatment. It is considered as a lifelong disease and the discontinuation of the medication can lead to relapse of the condition.

Technavio's analysts forecast the global bipolar disorder therapeutics market to grow at a CAGR of 2.24% over the period 2014-2019.

Get More Details on this Report and a Full Table of Contents at Global Biopolar Disorder Therapeutics Market 2015-2019

Covered in this report

The report covers the present scenario and growth prospects of the global bipolar disorder therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of bipolar disorder.

Technavio's report, Global Bipolar Disorder Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global bipolar disorder therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

-Americas
-APAC
-EMEA

Key vendors

-Allergan
-AstraZeneca
-BMS
-Eli Lilly
-GlaxoSmithKline
-Janssen Pharmaceuticals

Other prominent vendors

-AbbVie
-Abital Pharma
-Astellas
-Convergence Pharmaceuticals
-D Pharm
-Delpor
-Gedeon Richter
-H. Lundbeck
-Intra-Cellular Therapies
-Novartis
-Noven Pharmaceuticals
-Omeros Corporation
-Otsuka
-Pfizer
-PNBDevCo
-Reviva Pharmaceuticals
-SK Biopharmaceuticals
-Sunovion Pharmaceutical

Key market driver

-Increase in prevalence of bipolar disorder
-For a full, detailed list, view our report

Key market challenge

-Use of alternative therapies
-For a full, detailed list, view our report

Key market trend

-Rise in public awareness
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2019 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Allergan, AstraZeneca, BMS, Eli Lilly, GSK, Janssen Pharmaceuticals, AbbVie, Abital Pharma, Astellas, Convergence Pharmaceuticals, D Pharm, Delpor, Gedeon Richter, H. Lundbeck, Intra-Cellular Therapies, Novartis, Noven Pharmaceuticals, Omeros Corporation, Otsuka, Pfizer, PNBDevCo, Reviva Pharmaceuticals, SK Biopharmaceuticals, Sunovion Pharmaceutical.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019
-Global Opthalmic Therapeutic Market 2015-2019
-Glomerulonephritis Global Clinical Trials Review, H2, 2015
-Cancer Pain Global Clinical Trials Review, H1, 2015
-Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015